Brief: Aeon Biopharma, Priveterra Acquisition Corp Announce Filing Of S-4 Registration Statement For Proposed Business Combination
27/12/2022 14:05
Dec 27 (Reuters) - Priveterra Acquisition Corp PMGM.O :
* AEON BIOPHARMA AND PRIVETERRA ACQUISITION CORP. ANNOUNCE
FILING
OF S-4 REGISTRATION STATEMENT FOR PROPOSED BUSINESS COMBINATION
Source text for Eikon: ID:nBw5SG8Vma
Further company coverage: PMGM.O
((reuters.briefs@thomsonreuters.com;))
Recent news on Aeon Biopharma
See all newsBrief: Aeon Biopharma Reports bpd Type 2A Meeting With FDA And Shareholder Approval Of The November Transactions
Brief: Aeon Biopharma Announces Execution Of Exchange Agreement With Daewoong
Brief: Aeon Biopharma Announces First Closing Of Pipe Investment And Provides Update On FDA Type 2A Meeting Scheduling
Brief: Aeon Biopharma Announces FDA bpd Type 2A Meeting For Abp-450 On November 19
Brief: Aeon Biopharma Announces CEO Transition